Advertisement
Journal Home
Search for

Volume 4, Issue 2, Page A3 (March 2008)


View previous. 2 of 13 View next.

Contents

Refers to erratum:
Erratum
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
May 2008 (Vol. 4, Issue 3, Page 230)
Full Text | Full-Text PDF (81 KB)

Article Outline

Perspectives

Featured Articles

Association Pages

Perspectives 

return to Article Outline

65 Disease-modifying therapies in Alzheimer’s disease

Stephen Salloway, Jacobo Mintzer, Myron F. Weiner, Jeffrey L. Cummings

80 Partnership between academia and industry for drug discovery in Alzheimer’s disease

Adrian J. Ivinson, Roger Lane, Patrick C. May, David A. Hosford, Maria C. Carrillo, Eric R. Siemers

89 New directions for frontotemporal dementia drug discovery

John Q. Trojanowski, Karen Duff, Howard Fillit, Walter Koroshetz, Jeff Kuret, Diane Murphy, Larry Refolo

94 Commentary on “New directions for frontotemporal dementia drug discovery.” Do we know enough to develop meaningful treatments for frontotemporal dementia?

Dale Schenk

96 Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years

Gerda G. Fillenbaum, Gerald van Belle, John C. Morris, Richard C. Mohs, Suzanne S. Mirra, Patricia C. Davis, Pierre N. Tariot, Jeremy M. Silverman, Christopher M. Clark, Kathleen A. Welsh-Bohmer, Albert Heyman

Featured Articles 

return to Article Outline

110 2008 Alzheimer’s disease facts and figures

Alzheimer’s Association

134 Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?

Kenneth M. Langa, Eric B. Larson, Jason H. Karlawish, David M. Cutler, Mohammed U. Kabeto, Scott Y. Kim, Allison B. Rosen

145 The Atorvastatin/Donepezil in Alzheimer’s Disease Study (LEADe): Design and baseline characteristics

Roy W. Jones, Miia Kivipelto, Howard Feldman, Larry Sparks, Rachelle Doody, David D. Waters, Judith Hey-Hadavi, Andrei Breazna, Rachel J. Schindler, Harry Ramos, on behalf of the LEADe investigators

Association Pages 

return to Article Outline

154 Alzheimer’s Association Update

The pictures in the left column display early onset Alzheimer’s disease. Those in the right column display late onset Alzheimer’s disease. Beginning with the upper left figure and progressing clockwise, the images display severe neocortical atrophy, mild medial temporal atrophy, mild medial neocortical atrophy, and severe medial temporal atrophy. These images are provided as a courtesy by Dr. Giovanni Frisoni.

PII: S1552-5260(08)00040-X

doi:10.1016/S1552-5260(08)00040-X


View previous. 2 of 13 View next.